The Medicare anchor is slipping
Most commercial contracts are still written as a percentage of Medicare, so the Medicare Physician Fee Schedule and the hospital rules quietly set the ceiling for private pay. That anchor has weakened. The physician conversion factor has trailed the Medicare Economic Index for most of the last decade, and RAND's national hospital price studies continue to show commercial prices for hospital care running well above Medicare — roughly 250% of Medicare on average, with wide variation by market and service line.
The practical result is a widening spread between what Medicare pays and what commercial payers are willing to pay, and a growing incentive for payers to renegotiate percentage-of-Medicare clauses downward before the next fee-schedule cut flows through automatically.
If your commercial rates are indexed to Medicare, a tightening fee schedule is not neutral — it hands the payer a rate cut you never negotiated. Know which of your contracts float with Medicare and which are fixed-dollar before renewal season.
What changed the negotiating table
Three structural shifts have moved leverage toward payers in 2026:
- Medicare Advantage scale. With MA now covering more than half of eligible Medicare beneficiaries, payers increasingly set a single reimbursement philosophy across their MA and commercial books, and lean on Medicare-referenced rates in both.
- Transparency data. Payer price-transparency and hospital machine-readable files let both sides see negotiated rates across a market. That cuts both ways, but sophisticated payers have operationalized the data faster than most provider organizations.
- Consolidation on the payer side. National plans negotiate from portfolio-level data and standardized playbooks; a single hospital or physician group negotiating one contract at a time is structurally outmatched without comparable analytics.
Where rates are actually moving
The headline "commercial percent of Medicare" masks very different trajectories by setting and specialty. The table below is directional and should be read against your own market.
| Setting / segment | Direction vs. 2024 | Primary driver |
|---|---|---|
| Hospital inpatient | Flat to modestly up | Case-mix and high-acuity leverage remain |
| Hospital outpatient (HOPD) | Under pressure | Site-of-service scrutiny; payer steering to lower-cost sites |
| Ambulatory surgery centers | Up | Payers actively steering volume from HOPD |
| Primary & office-based E/M | Modestly up | Access value; behavioral and chronic-care demand |
| Hospital-based specialties (EM, radiology, anesthesia, pathology) | Contested | No Surprises Act / QPA linkage compresses out-of-network leverage |
Illustrative directional view for planning discussion; validate against your contracts and claims.
Building a defensible 2026 position
1. Separate the float from the fixed
Inventory every commercial agreement by whether its rates float with Medicare, escalate on a fixed schedule, or are locked. The float contracts are where a Medicare cut silently erodes margin.
2. Rebuild the benchmark from your own data
Percentage-of-Medicare is a negotiating shorthand, not a valuation. Model the actual cost and acuity of the services in each contract so you can argue rate on value delivered, not on a payer-supplied index.
3. Sequence the book
Renegotiate the contracts most exposed to Medicare drift first, and stage renewals so you are never renegotiating your weakest position under time pressure.
The organizations holding rate in 2026 are the ones that walked into the room with market-level transparency data and a service-line cost model — not just last year's rate plus an ask.